Vardenafil (Levitra/Staxyn) Cost in New Hampshire: 2026 Prices, Insurance, and Savings

What Vardenafil Costs in New Hampshire Right Now

The average cash price for generic vardenafil at New Hampshire retail pharmacies sits around $120 per month in 2026. Brand-name Levitra carries a manufacturer list price near $350 per month from Bayer, though few patients pay that figure out of pocket because generic alternatives have been available since 2018.

Prices vary across the state. Pharmacies in Manchester, Nashua, and Concord tend to cluster near the $120 average, while smaller independent pharmacies in rural areas may charge slightly more or less depending on their wholesale agreements. The price gap between brand and generic reflects a pattern seen nationally: once multiple generic manufacturers entered the market, per-tablet costs dropped by roughly 60 to 70 percent 1.

Staxyn, the orally disintegrating formulation of vardenafil, does not have an approved generic equivalent as of mid-2026. Patients who specifically need the ODT formulation will pay closer to the brand-name price point. For most men, however, the standard tablet works identically. The FDA-approved prescribing information confirms that the recommended starting dose is 10 mg taken approximately 60 minutes before sexual activity, with adjustments to 5 mg or 20 mg based on efficacy and tolerability.

A cost-per-use perspective helps. Men who use vardenafil four to eight times monthly will spend $15 to $30 per dose at generic cash prices. That makes it competitive with sildenafil (generic Viagra) and generally less expensive than tadalafil (generic Cialis) at equivalent frequency.

New Hampshire Medicaid and Vardenafil Coverage

Medicaid in New Hampshire does not cover vardenafil for erectile dysfunction. This is consistent with a broader pattern across state Medicaid programs. Following the Deficit Reduction Act of 2005, the Centers for Medicare and Medicaid Services permitted states to exclude erectile dysfunction drugs from Medicaid formularies, and most states, including New Hampshire, exercised that option 2.

New Hampshire's Medicaid managed care plans (administered through AmeriHealth Caritas and Well Sense) follow this same exclusion. Prior authorization will not override it. The exclusion applies regardless of the underlying diagnosis causing ED, whether it stems from diabetes, prostate surgery, or spinal cord injury.

For Medicaid-enrolled patients seeking affordable access, two pathways remain. First, manufacturer discount programs (discussed below) may bring costs below $50 per month. Second, compounded vardenafil through a licensed 503A pharmacy provides another option at potentially lower cost. Neither pathway uses the Medicaid benefit itself, so patients pay out of pocket.

Medicare Part D behaves differently from Medicaid. While Part D plans historically excluded ED medications under the same federal guidance, the Inflation Reduction Act and subsequent CMS bulletins have nudged some Part D plans to reconsider coverage on a plan-by-plan basis. New Hampshire Medicare beneficiaries should check their specific Part D formulary each enrollment period.

Insurance Coverage for Vardenafil in New Hampshire

Private insurance coverage for vardenafil varies widely across New Hampshire carriers. Most plans that do cover it place generic vardenafil on Tier 2 or Tier 3, with copays typically running $30 to $75 for a 30-day supply. Brand Levitra, when covered at all, usually lands on a non-preferred brand tier with copays above $100.

Major insurers operating in New Hampshire include Anthem Blue Cross Blue Shield, Cigna, Harvard Pilgrim Health Care, and Ambetter (from NH Healthy Families). Coverage details:

Anthem plans in New Hampshire generally cover generic vardenafil with step therapy requiring a trial of sildenafil first. Cigna follows a similar step-therapy protocol but may waive it if the prescriber documents sildenafil intolerance or contraindication, such as concurrent use of an alpha-blocker where vardenafil's pharmacokinetic profile may be preferred 3.

Harvard Pilgrim covers generic vardenafil on most commercial plans but limits quantities to 8 to 12 tablets per month. Ambetter plans through the ACA marketplace in New Hampshire have the most restrictive formularies and frequently exclude all PDE5 inhibitors from standard coverage.

Patients denied coverage should request a formulary exception. New Hampshire RSA 420-J:7-a requires insurers to respond to exception requests within 72 hours (24 hours for urgent cases). A letter from the prescribing physician citing clinical necessity and prior treatment failures strengthens these requests significantly.

Compounded Vardenafil in New Hampshire: Legality and Access

Compounded vardenafil is legal in New Hampshire through licensed 503A pharmacies. These are pharmacies operating under section 503A of the Federal Food, Drug, and Cosmetic Act, which allows patient-specific compounding based on a valid prescription 4.

The New Hampshire Board of Pharmacy regulates compounding pharmacies under NH RSA 318. Pharmacies must hold a valid state license and comply with USP <795> standards for non-sterile compounding. Several compounding pharmacies in the state prepare vardenafil tablets or troches, sometimes combined with other agents in a combination ED formulation.

Why choose compounded vardenafil? Three reasons drive patients toward this option. Dose customization is the primary advantage. Commercial vardenafil comes in 5 mg, 10 mg, and 20 mg tablets only. A compounding pharmacy can prepare intermediate doses (7.5 mg, 15 mg) or combination formulations that pair vardenafil with other vasodilators. Second, some patients who experience specific side effects from tablet fillers or dyes in the commercial product tolerate a compounded version without those inactive ingredients. Third, pricing at 503A pharmacies can undercut retail generic prices, particularly for patients paying cash.

One limitation applies: 503B outsourcing facilities (which compound without individual prescriptions for "office use") operate under different federal rules. Vardenafil produced by a 503B facility may be used in clinical settings but follows stricter FDA oversight than 503A patient-specific compounding.

Patients considering compounded vardenafil should verify that their pharmacy holds current New Hampshire Board of Pharmacy licensure and ask whether the pharmacy has passed its most recent state inspection.

Telehealth Prescribing of Vardenafil in New Hampshire

New Hampshire permits telehealth prescribing of vardenafil without restrictions specific to ED medications. The state's telehealth framework, codified under NH RSA 329:1-d, allows licensed prescribers to evaluate patients and prescribe medications via synchronous audio-video encounters. An initial in-person visit is not required.

This matters for cost. Telehealth platforms frequently bundle the consultation fee and medication into a single monthly price. Several national telehealth platforms operating in New Hampshire offer generic vardenafil prescriptions with home delivery, often pricing the combined package between $80 and $150 per month depending on quantity.

Prescribers must hold an active New Hampshire medical license or practice under the Interstate Medical Licensure Compact, which New Hampshire joined. The prescriber must document an appropriate medical evaluation, including cardiovascular risk assessment, before prescribing any PDE5 inhibitor. The American Urological Association's 2018 guidelines recommend assessing cardiovascular fitness and potential drug interactions (particularly with nitrates, which are an absolute contraindication) before initiating therapy 5.

HealthRX offers telehealth consultations with licensed providers who can prescribe vardenafil to eligible New Hampshire residents, with medication shipped directly to the patient.

How Vardenafil Compares on Price to Other ED Drugs in New Hampshire

Vardenafil occupies a middle tier in New Hampshire ED drug pricing. Generic sildenafil (Viagra) is the least expensive option, averaging $30 to $80 per month for on-demand use. Generic vardenafil falls in the $100 to $140 range. Generic tadalafil (Cialis) for daily 5 mg dosing runs $60 to $120 per month, while on-demand tadalafil (10 or 20 mg) costs $90 to $150.

Brand-name pricing tells a different story. Levitra at $350 per month exceeds Viagra ($400+ but with steeper generic discounting) and falls below Cialis ($450+). The brand-versus-generic gap is widest for sildenafil, narrowest for tadalafil.

The clinical choice between these medications should not rest on price alone. Vardenafil demonstrated strong efficacy in the original registration trial by Porst et al. (2003), where 20 mg vardenafil produced statistically significant improvements in erectile function domain scores versus placebo across all severity subgroups 1. The study enrolled 580 men and showed that 65% of intercourse attempts were successful with vardenafil 20 mg, compared to 32% with placebo (P<0.001).

Vardenafil may offer specific advantages for certain patient profiles. A 2011 meta-analysis published in European Urology found that vardenafil had a faster median onset of action (approximately 25 minutes) compared to sildenafil (approximately 30 minutes), though individual response varies 6. For men who prioritize rapid onset over duration of effect, vardenafil can be the preferred agent.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a lead author on the AUA erectile dysfunction guideline, has stated: "PDE5 inhibitor selection should be individualized. Factors including onset of action, duration, side-effect profile, and patient preference all weigh into the decision, not cost alone" 5.

Discount Programs and Savings Cards for New Hampshire Patients

Several discount pathways can reduce vardenafil costs for New Hampshire residents. Manufacturer savings cards from generic vardenafil producers vary by company and are not universally available, but when offered, they typically reduce copays by $20 to $50 per fill at participating pharmacies.

Pharmacy discount programs provide the most consistent savings. GoodRx, RxSaver, and similar platforms aggregate discount pricing from New Hampshire pharmacies and frequently show prices 20 to 40 percent below the cash price. These programs are free to use and work at most chain pharmacies including CVS, Walgreens, and Rite Aid locations throughout the state.

Costco pharmacies (there are two locations in New Hampshire, in Nashua and Manchester) often have the lowest retail cash prices for generic medications, and you do not need a Costco membership to use the pharmacy. Generic vardenafil pricing at Costco pharmacies has historically run 15 to 25 percent below the state average.

For patients using eight or fewer tablets per month, per-tablet pricing matters more than monthly pricing. Some pharmacies offer better deals on quantities of 4 or 6 tablets rather than a full 30-day supply, since most men do not use vardenafil daily.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) ships to New Hampshire and prices generic vardenafil on a transparent cost-plus model. Pricing through this mail-order pharmacy has been consistently below $1 per milligram, making a 10 mg dose under $10 per tablet.

Safety Considerations and Prescribing Requirements

Vardenafil requires a prescription in New Hampshire and in every U.S. state. No legitimate pathway exists to obtain it over the counter. The FDA label carries specific warnings that every patient should know.

Absolute contraindication: concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) in any form. Combining vardenafil with nitrates can cause life-threatening hypotension 7. This contraindication extends to recreational nitrate ("poppers") use.

QTc prolongation is a unique safety concern for vardenafil compared to other PDE5 inhibitors. The FDA label notes that vardenafil can prolong the QT interval, and it should be avoided in patients taking Class IA (quinidine, procainamide) or Class III (amiodaril, sotalol) antiarrhythmics 8. Neither sildenafil nor tadalafil carries this same warning.

Common side effects in clinical trials included headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) 1. These rates are comparable to other PDE5 inhibitors.

New Hampshire prescribers should document cardiovascular risk stratification before initiating any PDE5 inhibitor, consistent with the Princeton III Consensus recommendations published in the Journal of Sexual Medicine 9.